|Bid||33.4900 x 1800|
|Ask||33.5000 x 10500|
|Day's Range||33.4500 - 33.5750|
|52 Week Range||29.8300 - 37.3900|
|PE Ratio (TTM)||28.19|
|Dividend & Yield||1.28 (3.81%)|
|1y Target Est||N/A|
Johnson & Johnson (JNJ) reported a revenue increase of ~2.9% between 2Q16 and 2Q17. The company’s business is broken down into three business segments: Pharmaceuticals, Consumer Products, and Medical Devices. ...
Merck & Co., Inc.'s (MRK) new products like Keytruda, Zepatier and Bridion are likely to drive sales in Q2. However, headwinds remain in the form genericization of key drugs and increasing competition.
In the U.S., one in eight women will be diagnosed with breast cancer in their lifetime; for men, the risk is one in 1,000.